IPO Databook: Ming Yu Pharmaceutical (HK) - Jul 2026
Ming Yu Pharmaceutical, established in 2018, focuses on oncology (ADCs, immunotherapies) and advanced autoimmune assets, seeking HKEX Chapter 18A...
132 Views
Primer: Ming Yu Pharmaceutical (MYP HK) - Aug 2026
Ming Yu Pharmaceutical is a clinical-stage biotechnology company with a strategic focus on developing innovative therapies for oncology and...
94 Views
Ming Yu (明宇制药) Pre-IPO: Prospectus Update Suggests Mixed Views Across Products
Ming Yu Pharmaceutical filed an updated prospectus for a HKEX Chapter 18A listing. We analyse the changes in its pipeline and competitive landscape...
109 Views
Ming Yu Pharmaceutical (MYP HK): Synthetic Expert Call Transcript (09 Jul 2026)
The SuperTopoi platform's claim of 5-10x potency over DXd-based ADCs is primarily a preclinical metric; in clinical settings, this extreme potency...
117 Views
Pre-IPO Ming Yu Pharmaceutical - Popular Products Do Not Necessarily Guarantee Commercial Success
All core pipelines of Ming Yu face fierce competition, without commercialized products on the market.Success hinges on R&D resources and...
241 Views